home / stock / ndra / ndra news

NDRA News and Press, ENDRA Life Sciences Inc.

Stock Information
Company Name: ENDRA Life Sciences Inc.
Stock Symbol: NDRA
Market: NASDAQ
Website: endrainc.com
Menu
NDRA NDRA Quote NDRA Short NDRA News NDRA Articles NDRA Message Board
Get NDRA Alerts

News, Short Squeeze, Breakout and More Instantly...
NDRA - ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care

Achieved Intraclass Correlation Coefficient (ICC) of 0.89 with standard error of measurement (SEM) of 3.3% using independent operators ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for ...
NDRA - ENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”) , a p...

NDRA - ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

TAEUS Liver demonstrates strong agreement with the industry’s imaging gold standard, MRI‑PDFF, across the full spectrum of steatotic liver disease and patient BMI ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pionee...

NDRA - Endra Life Sciences GAAP EPS of -$2.10 misses by $0.15

2025-11-17 08:23:06 ET More on Endra Life Sciences ENDRA Life Sciences announces at-market private placement of up to $14.4M Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings data for Endra Life Sciences Financial information for ...
NDRA - ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (“MASLD”) and metabolic dysfunction associated steat...

NDRA - ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

ENDRA is converting static treasury assets into a dynamic rewards engine to support medical innovation ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in imaging technologies for the early detection and monitoring of metabo...

NDRA - ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Company Officially Launches Digital Asset Treasury Strategy Focused on the Highest Conviction Holdings of Arca Investment Management to Enhance Long-Term Shareholder Value ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in ...
NDRA - Spider Silk, Spines, and Satoshi - Innovation Headlines Today's Movers

2025-10-13 10:10:27 ET DENVER, Colo., Oct 13, 2025 ( 247marketnews.com )- Kraig Biocraft Laboratories (OTCQB:KBLB) surged into the spotlight this morning after announcing a major breakthrough in its recombinant spider silk production. The company unveiled BAM-1 Alpha , a new sil...

NDRA - ENDRA Life Sciences Leans into Crypto with Bold Treasury Strategy

2025-10-13 08:20:17 ET DENVER, Colo., Oct 13, 2025 ( 247marketnews.com )- In a strategic pivot that blends biotech innovation with digital finance, ENDRA Life Sciences (NASDAQ:NDRA) announced a private placement of up to $14.4 million aimed at launching a digital asset treasury (DAT) st...

NDRA - ENDRA Life Sciences announces at-market private placement of up to $14.4M

2025-10-13 08:14:01 ET More on Endra Life Sciences Endra Life Sciences GAAP EPS of -$1.71 beats by $0.56 Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings data for Endra Life Sciences Financial information for Endra Life Sciences ...
Next 10